Metropolis Healthcare Ltd Analyst Rating
based on 17 analysts
58.82%
Buy
5.88%
Hold
35.29%
Sell
Based on 17 analysts offering long term price targets for Metropolis Healthcare Ltd. An average target of ₹2141.53
Source: S&P Global Market Intelligence
Metropolis Healthcare Ltd Share analysis
Metropolis Healthcare Ltd price forecast by 17 analysts
Upside of5.98%
High
₹2490
Target
₹2141.53
Low
₹1691
Metropolis Healthcare Ltd target price ₹2141.53, a slight upside of 5.98% compared to current price of ₹2015.75. According to 17 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Metropolis Healthcare Ltd revenue growth forecast
Expected growth rate Q1, FY2026:28.05%
Forecast
Actual
Including amortisation and stock based compensations
Metropolis Healthcare Ltd EPS growth forecast
EPS estimate Q1, FY2026:76.35%
Forecast
Actual
Source: S&P Global Market Intelligence
Metropolis Healthcare Ltd Performance
Day's Low
Day's High
₹1,988.15₹2,021.4552 Week's Low
52 Week's High
₹1,450₹2,318.3
| Returns % | |
| 1 Month Return | -7.16 % |
| 3 Month Return | -3.59 % |
| 1 Year Return | + 23.57 % |
| Market Stats | |
| Previous Close | ₹2,020.70 |
| Open | ₹2,007.80 |
| Volume | 75.29K |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹10,359.59Cr |
Metropolis Healthcare Ltd Key Statistics
| P/E Ratio | 69.92 |
| PEG Ratio | 24.45 |
| Market Cap | ₹10,359.59 Cr |
| P/B Ratio | 8.58 |
| EPS | 25.08 |
| Dividend Yield | 0.23 |
| Sector | Healthcare |
| ROE | 11.78 |
Metropolis Healthcare Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| HOLD | ₹10,359.59 Cr | 8.09% | 0.58 | ₹128 Cr | ₹1,207 Cr | |
| BUY | ₹10,968.52 Cr | 14.47% | 0.64 | ₹119 Cr | ₹547 Cr | |
| BUY | ₹5,102.04 Cr | 14.44% | 0.54 | ₹69 Cr | ₹571 Cr | |
| HOLD | ₹25,420.21 Cr | 18.47% | 0.55 | ₹362 Cr | ₹2,226 Cr | |
| HOLD | ₹26,364.89 Cr | 126.87% | 0.67 | ₹168 Cr | ₹5,040 Cr |
Metropolis Healthcare Ltd Mutual Fund Holdings
About Metropolis Healthcare Ltd
The company offers a wide range of products and services, including clinical laboratory services, imaging services, pathology services, and wellness services. Metropolis Healthcare Ltd also provides a range of specialty services, such as genetic testing, molecular diagnostics, and bio-banking. It is one of the leading providers of healthcare services in India.
The company's top products include clinical laboratory tests, imaging services, pathology services, and wellness services. It also offers a range of popular services under the brands: Metropolis, Metropolis Health Plus, Metropolis Health Care, and Metropolis Health Care Plus.
Share Price: ₹2015.75 per share as on 21 Nov, 2024 04:01 PM
Market Capitalisation: ₹10,359.59Cr as of today
Revenue: ₹349.79Cr as on September 2024 (Q3 24)
Net Profit: ₹46.70Cr as on September 2024 (Q3 24)
Listing date: 15 Apr, 2019
Chairperson Name: Sushil Kanubhai Shah
| Organisation | Metropolis Healthcare Ltd |
| Headquarters | |
| Industry | Healthcare |
| E-voting on shares | Click here to vote |
Key events for Metropolis Healthcare Ltd
Metropolis Healthcare Expands Reach to 1,000 Towns - 13 Nov, 2024
Metropolis Healthcare Ltd is set to expand its presence to 1,000 towns from 700, focusing on Tier-II and Tier-III cities with an investment of Rs 65 crore over two years.
Metropolis Healthcare Reports Growth Amid Expansion Plans - 12 Nov, 2024
Metropolis Healthcare shows strong performance with a 31% profit increase in Q2FY25 and plans to expand to 1,000 towns. Goldman Sachs maintains a 'Sell' rating, while Emkay Global retains a 'Buy' rating with a target of Rs 2,400. Ameera Shah's leadership is acknowledged for significant revenue growth.
Metropolis Healthcare Reports Strong Q2 Earnings Growth - 11 Nov, 2024
Metropolis Healthcare's consolidated net profit rose 31% in Q2 FY2025, with net sales increasing by 13.38%. EPS also improved significantly, reflecting strong financial performance.
Metropolis Healthcare Reports Strong Financial Growth - 10 Nov, 2024
Metropolis Healthcare Ltd announced a solid performance with a 31% increase in net profit to ₹47 crore and an 11.5% revenue growth to ₹349 crore, driven by higher patient volumes and test demand, particularly in Maharashtra and Specialty services.
Metropolis Healthcare Reports Strong Q2 Earnings Growth - 09 Nov, 2024
Metropolis Healthcare's consolidated net profit increased by 31.23% to Rs 46.52 crore in Q2 FY25, driven by a 13.38% rise in revenue. The company also appointed Aditya Shinde as Interim CFO.
Metropolis Healthcare Reports Strong Q2 Results and CFO Appointment - 08 Nov, 2024
Metropolis Healthcare announced a 31% YoY profit increase for Q2 FY25, reaching ₹46.7 crore, alongside the appointment of Aditya Shinde as Interim CFO. The company experienced significant revenue growth, driven by patient volume increases and expansion into tier 3 cities.
Metropolis Reports Rise in Autoimmune Conditions Post-COVID - 21 Oct, 2024
A study by Metropolis Healthcare reveals a 30% increase in antinuclear antibody positivity in India post-COVID-19, indicating a rise in autoimmune diseases linked to the pandemic.
Insights on Metropolis Healthcare Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTFII Holding Up
Foreign Institutions have increased holdings from 18.25% to 18.56% in Sep 2024 quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 315.81 Cr → 352.92 Cr (in ₹), with an average increase of 10.5% per quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 4 quarters, 27.16 Cr → 46.52 Cr (in ₹), with an average increase of 16.0% per quarter
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 23.67% to 24.33% in Sep 2024 quarter
NO EFFECTAgainst Peers
In the last 3 years, Max Healthcare Institute Ltd has given 191.3% return, outperforming this stock by 224.6%
- NO EFFECT
Against Peers
In the last 1 year, Fortis Healthcare Ltd has given 76.6% return, outperforming this stock by 53.1%
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 4.70% to 3.99% in Sep 2024 quarter
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 49.62% to 49.43% in Sep 2024 quarter
- NEGATIVE IMPACT
Price Dip
In the last 3 years, METROPOLIS stock has moved down by -33.3%
Metropolis Healthcare Ltd Financials
Index Inclusions
Metropolis Healthcare Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 49.43% | ||
| Foreign Institutions | 18.56% | 1.68 | |
| Mutual Funds | 24.33% | 2.76 | |
| Retail Investors | 3.99% | ||
| Others | 3.69% |
Metropolis Healthcare Ltd Key Indicators
Metropolis Healthcare Ltd Valuation
Metropolis Healthcare Ltd in the last 5 years
Lowest (33.38x)
June 22, 2022
Today (69.92x)
November 19, 2024
Industry (96.41x)
November 19, 2024
Highest (98.05x)
September 15, 2020
Metropolis Healthcare Ltd Earnings and Dividends
Metropolis Healthcare Ltd Earnings Results
Metropolis Healthcare Ltd’s net profit jumped 31.23% since last year same period to ₹46.52Cr in the Q2 2024-2025. On a quarterly growth basis, Metropolis Healthcare Ltd has generated 22.58% jump in its net profits since last 3-months.
Read More about Earnings ResultsMetropolis Healthcare Ltd Dividends November,2023
In the quarter ending September 2023, Metropolis Healthcare Ltd has declared dividend of ₹4 - translating a dividend yield of 0.59%.
Read More about Dividends
Metropolis Healthcare Ltd Technicals Summary
Bearish
Neutral
Bullish
Metropolis Healthcare Ltd is currently in a Bearish trading position according to technical analysis indicators.
FAQs on Metropolis Healthcare Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Metropolis Healthcare Ltd shares.
Metropolis Healthcare Ltd (METROPOLIS) share price today is ₹2015.75
Metropolis Healthcare Ltd is listed on NSE
Metropolis Healthcare Ltd is listed on BSE
- Today’s highest price of Metropolis Healthcare Ltd is ₹2021.45.
- Today’s lowest price of Metropolis Healthcare Ltd is ₹1988.15.
PE Ratio of Metropolis Healthcare Ltd is 69.92
PE ratio = Metropolis Healthcare Ltd Market price per share / Metropolis Healthcare Ltd Earnings per share
Today’s traded volume of Metropolis Healthcare Ltd(METROPOLIS) is 75.29K.
Today’s market capitalisation of Metropolis Healthcare Ltd(METROPOLIS) is ₹10359.59Cr.
| Metropolis Healthcare Ltd(METROPOLIS | Price |
|---|---|
52 Week High | ₹2318.3 |
52 Week Low | ₹1450 |
Metropolis Healthcare Ltd(METROPOLIS) share price is ₹2015.75. It is down -13.05% from its 52 Week High price of ₹2318.3
Metropolis Healthcare Ltd(METROPOLIS) share price is ₹2015.75. It is up 39.02% from its 52 Week Low price of ₹1450
| Metropolis Healthcare Ltd(METROPOLIS | Returns |
|---|---|
1 Day Returns | -4.95% |
1 Month Returns | -7.16% |
3 Month Returns | -3.59% |
1 Year Returns | 23.57% |